Sepsis Test Shows the Value of Rapid Diagnosis  Â
Two case studies illustrate how a newly developed sepsis test improves turnaround times and diagnostic accuracy.
Two case studies illustrate how a newly developed sepsis test improves turnaround times and diagnostic accuracy.
CareDx, Inc. has announced that its AlloSure Lung donor-derived cell-free DNA molecular testing service has received Medicare coverage.
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Research underscores the positive outcomes of exome sequencing for individuals with ASD, supporting its use to reach a faster diagnosis.
Read MoreGenetic testing can diagnose cardiomyopathy in children and help detect who will have heart failure and require a transplant.
Read MoreCue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read MoreUCLA researchers have found a cost-effective way for early detection of cancer using cell-free DNA in blood samples.
Read MoreTheranos whistleblower Tyler Shultz sees what he did as an in-case-of-emergency break glass option. But who should be the industry watchmen?
Read MoreBD announced the U.S. launch of its new, fully automated, high-throughput infectious disease molecular diagnostics platform.
Read MoreA 384-well option is now available for Thermo Fisher Scientific’s Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System.
Read MorePanther Trax’s broad assay menu includes tests for women’s health, sexually transmitted infections (STIs), respiratory health, COVID-19 testing, and more.
Read MoreBD has expanded its BD COR System to include a new MX instrument for high-throughput molecular testing for infectious diseases.
Read MoreApplied BioCode has released 28 Fungal Analyte-Specific Reagents for use in molecular tests, which utilize the company’s BMB technology.
Read MoresimplSEQ, Inc. presented a poster showing the value of its technology in isolating DNA and RNA from whole blood at the 2021 AMP annual meeting.
Read MoreAsuragen Inc. has launched a testing kit for research use that is designed to detect pathogenic variants in the CFTR gene that cause cystic fibrosis.
Read MoreBiocept’s Switch-Blocker technology enhances the performance of conventional PCR-based liquid biopsy assays in detecting rare cancer mutations.
Read MoreThermo Fisher Scientific has expanded its diagnostics portfolio to support full qPCR assay development and testing workflow.
Read MoreBioGenex Laboratories announces the NanoVIP, an automated benchtop system for in situ hybridization that can run 10 different protocols simultaneously.
Read More